Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 315

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Adjunctive Dexamethasone in HIV-Associated Cryptococcal Meningitis

Open access
Beardsley, Justin, Wolbers, Marcel, Kibengo, Freddie M., Ggayi, Abu-Baker M., Kamali, Anatoli, Cuc, Ngo Thi Kim, Binh, Tran Quang, Chau, Nguyen Van Vinh, Farrar, Jeremy, Merson, Laura, Phuong, Lan, Thwaites, Guy, Van Kinh, Nguyen, Thuy, Pham Thanh, Chierakul, Wirongrong, Siriboon, Suwatthiya, Thiansukhon, Ekkachai, Onsanit, Satrirat, Supphamongkholchaikul, Watthanapong, Chan, Adrienne K., Heyderman, Robert, Mwinjiwa, Edson, van Oosterhout, Joep J., Imran, Darma, Basri, Hasan, Mayxay, Mayfong, Dance, David, Phimmasone, Prasith, Rattanavong, Sayaphet, Lalloo, David G., Day, Jeremy N.·2016·New England Journal of Medicine

Abstract

BACKGROUND: Cryptococcal meningitis associated with human immunodeficiency virus (HIV) infection causes more than 600,000 deaths each year worldwide. Treatment has changed little in 20 years, and there are no imminent new anticryptococcal agents. The use of adjuvant glucocorticoids reduces mortality among patients with other forms of meningitis in some populations, but their use is untested in patients with cryptococcal meningitis. METHODS: In this double-blind, randomized, placebo-controlled trial, we recruited adult patients with HIV-associated cryptococcal meningitis in Vietnam, Thailand, Indonesia, Laos, Uganda, and Malawi. All the patients received either dexamethasone or placebo for 6 weeks, along with combination antifungal therapy with amphotericin B and fluconazole. RESULTS: The trial was stopped for safety reasons after the enrollment of 451 patients. Mortality was 47% in the dexamethasone group and 41% in the placebo group by 10 weeks (hazard ratio in the dexamethasone group, 1.11; 95% confidence interval [CI], 0.84 to 1.47; P=0.45) and 57% and 49%, respectively, by 6 months (hazard ratio, 1.18; 95% CI, 0.91 to 1.53; P=0.20). The percentage of patients with disability at 10 weeks was higher in the dexamethasone group than in the placebo group, with 13% versus 25% having a prespecified good outcome (odds ratio, 0.42; 95% CI, 0.25 to 0.69; P<0.001). Clinical adverse events were more common in the dexamethasone group than in the placebo group (667 vs. 494 events, P=0.01), with more patients in the dexamethasone group having grade 3 or 4 infection (48 vs. 25 patients, P=0.003), renal events (22 vs. 7, P=0.004), and cardiac events (8 vs. 0, P=0.004). Fungal clearance in cerebrospinal fluid was slower in the dexamethasone group. Results were consistent across Asian and African sites. CONCLUSIONS: Dexamethasone did not reduce mortality among patients with HIV-associated cryptococcal meningitis and was associated with more adverse events and disability than was placebo. (Funded by the United Kingdom Department for International Development and others through the Joint Global Health Trials program; Current Controlled Trials number, ISRCTN59144167.).

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmoa1509024

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 29 references

Cited by

See all 315

Metadata

Authors
Beardsley, J., Wolbers, M., Kibengo, F. M., Ggayi, A.-B. M., Kamali, A., Cuc, N. T. K., Binh, T. Q., Chau, N. V. V., Farrar, J., Merson, L., Phuong, L., Thwaites, G., Van Kinh, N., Thuy, P. T., Chierakul, W., Siriboon, S., Thiansukhon, E., Onsanit, S., Supphamongkholchaikul, W., Chan, A. K., Heyderman, R., Mwinjiwa, E., van Oosterhout, J. J., Imran, D., Basri, H., Mayxay, M., Dance, D., Phimmasone, P., Rattanavong, S., Lalloo, D. G., & Day, J. N.
Venue
New England Journal of Medicine
Published
2016-02-11
Volume
374
Issue
6
Pages
542-554
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2277731646
Cited by
315
References
29
FWCI
37.62
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Adjunctive Dexamethasone in HIV-Associated Cryptococcal Meningitis. https://app.cochat.ai/papers/10.1056/nejmoa1509024
The paper
Beardsley, J., Wolbers, M., Kibengo, F. M., Ggayi, A.-B. M., Kamali, A., Cuc, N. T. K., Binh, T. Q., Chau, N. V. V., Farrar, J., Merson, L., Phuong, L., Thwaites, G., Van Kinh, N., Thuy, P. T., Chierakul, W., Siriboon, S., Thiansukhon, E., Onsanit, S., Supphamongkholchaikul, W., . . . Day, J. N. (2016). Adjunctive Dexamethasone in HIV-Associated Cryptococcal Meningitis. New England Journal of Medicine. https://doi.org/10.1056/nejmoa1509024

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.